MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
Sodium Iodide I-131 Kits and Capsules Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities
Sodium Iodide I-131 Kits and Capsules by Type (/> Capsule, Solution), by Application (/> Hyperthyroidism Treatment, Thyroid Cancer Treatment), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
Base Year: 2025
107 Pages
Sodium Iodide I-131 Kits and Capsules Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities
Sodium Iodide I-131 Kits and Capsules Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities
The global Sodium Iodide I-131 Kits and Capsules market is projected for substantial growth, driven by the increasing incidence of thyroid disorders such as hyperthyroidism and thyroid cancer. The market, valued at $14.31 billion in the base year 2025, is expected to expand at a Compound Annual Growth Rate (CAGR) of 9.18% through 2033. Key growth drivers include advancements in nuclear medicine, enhancing treatment precision and efficacy; improved diagnostic capabilities, facilitating early disease detection; and a growing elderly population with higher susceptibility to thyroid conditions. Increased awareness and treatment accessibility in emerging economies also contribute to market expansion. Segmentation by product type (kits, capsules) and application (hyperthyroidism, thyroid cancer treatment) both indicate strong growth potential.
Sodium Iodide I-131 Kits and Capsules Market Size (In Billion)
25.0B
20.0B
15.0B
10.0B
5.0B
0
14.31 B
2025
15.62 B
2026
17.06 B
2027
18.62 B
2028
20.33 B
2029
22.20 B
2030
24.24 B
2031
Prominent market players, including Curium Pharma, China Isotope & Radiation Corporation (CIRC), and Jubilant Pharmova, are actively involved in innovation and market penetration. Geographically, North America and Europe lead the market, with the Asia-Pacific region anticipated to experience significant growth due to rising healthcare spending and adoption rates.
Sodium Iodide I-131 Kits and Capsules Company Market Share
Loading chart...
The competitive landscape is characterized by moderate intensity, with established and emerging companies competing through strategic alliances, mergers, acquisitions, and continuous product innovation. Regulatory compliance and stringent quality control are vital for market entry and sustained success. Future growth will be shaped by the development of novel radiopharmaceuticals, advancements in radiation therapy technology, and evolving healthcare policies. The increasing demand for effective thyroid disorder treatments globally, coupled with ongoing R&D efforts to enhance Sodium Iodide I-131 therapies, will fuel significant market expansion.
Sodium Iodide I-131 Kits and Capsules Trends
The global market for Sodium Iodide I-131 kits and capsules is experiencing robust growth, projected to reach multi-million unit sales by 2033. Driven by increasing prevalence of thyroid disorders and advancements in nuclear medicine, the market demonstrates a significant upward trajectory throughout the forecast period (2025-2033). Analysis of the historical period (2019-2024) reveals a steady rise in demand, exceeding expectations in several key regions. This growth is further fueled by continuous technological improvements in radiopharmaceutical production, leading to enhanced efficacy and safety profiles of I-131 products. The market is witnessing a shift towards more sophisticated and user-friendly kits, simplifying administration and reducing the complexity of procedures for healthcare professionals. This, in turn, is expanding access to treatment and contributing to market expansion. The competitive landscape is dynamic, with both established players and emerging companies vying for market share through product innovation, strategic partnerships, and geographic expansion. While the capsule format remains prevalent, the solution form is gaining traction due to its versatility and potential for improved patient compliance. The estimated market value for 2025 positions the industry for considerable future expansion, promising lucrative opportunities for stakeholders. The report also highlights a regional disparity, with certain areas exhibiting significantly higher growth rates than others, driven by factors such as healthcare infrastructure development and disease prevalence. Overall, the market showcases a promising outlook, propelled by technological advancements, rising healthcare expenditure, and increasing awareness of thyroid-related conditions.
Driving Forces: What's Propelling the Sodium Iodide I-131 Kits and Capsules Market?
Several key factors are driving the expansion of the Sodium Iodide I-131 kits and capsules market. The escalating incidence of thyroid cancer and hyperthyroidism globally forms the primary impetus for growth. Improved diagnostic capabilities are leading to earlier detection and treatment, further boosting demand. Advances in radiopharmaceutical technology have resulted in safer and more effective I-131 products, enhancing treatment outcomes and patient satisfaction. Increased healthcare spending, particularly in developing economies, is also contributing to market expansion by improving access to advanced medical therapies. The growing awareness among patients and healthcare professionals regarding the efficacy of I-131 treatment plays a crucial role in market growth. Furthermore, government initiatives promoting early cancer detection and improved healthcare infrastructure are indirectly contributing to the market's upward trajectory. Stringent regulatory approvals and quality control measures ensure the safety and efficacy of I-131 products, bolstering patient and physician confidence, thereby increasing demand. The continuous research and development activities focused on enhancing I-131 delivery methods and improving treatment protocols further enhance the market's growth potential.
Challenges and Restraints in Sodium Iodide I-131 Kits and Capsules Market
Despite the promising growth outlook, several challenges hinder the Sodium Iodide I-131 kits and capsules market. The high cost associated with I-131 treatment poses a significant barrier to accessibility, particularly in low- and middle-income countries. Stringent regulatory requirements and lengthy approval processes can delay product launches and limit market entry for new players. The potential side effects associated with I-131 therapy, although rare, can cause apprehension among patients and healthcare professionals. The need for specialized infrastructure and trained personnel for I-131 administration limits the availability of treatment in many regions. Competition from alternative thyroid treatment modalities, such as surgery and radioactive iodine therapy using different isotopes, can also affect market growth. The complex logistics involved in the handling, transportation, and disposal of radioactive materials present logistical and safety challenges. Fluctuations in the prices of raw materials used in I-131 production can impact the overall cost and profitability of the market. Finally, concerns regarding radiation exposure and its long-term effects can create apprehension among patients and healthcare professionals.
Key Region or Country & Segment to Dominate the Market
The North American and European markets currently dominate the Sodium Iodide I-131 kits and capsules market, driven by advanced healthcare infrastructure, high prevalence of thyroid disorders, and significant healthcare expenditure. However, the Asia-Pacific region is projected to experience the fastest growth rate due to increasing awareness, rising healthcare expenditure, and expanding access to advanced medical treatments. Within segments, the Thyroid Cancer Treatment application holds the largest market share due to the higher prevalence of thyroid cancer compared to hyperthyroidism. The solution form is witnessing increased adoption owing to its ease of administration and potential for improved patient compliance.
North America: High healthcare spending, well-established healthcare infrastructure, and increased awareness of thyroid disorders contribute to the region's market dominance.
Europe: Similar to North America, Europe benefits from a well-developed healthcare system and high healthcare expenditure, sustaining robust market growth.
Asia-Pacific: Rapidly expanding healthcare infrastructure, rising disposable incomes, and increasing awareness of thyroid disorders are driving significant growth in this region.
Thyroid Cancer Treatment Segment: The higher prevalence of thyroid cancer compared to hyperthyroidism contributes to this segment's dominant market share.
Solution Form: The ease of administration and potential for improved patient compliance are key drivers for the increased adoption of the solution form.
Growth Catalysts in Sodium Iodide I-131 Kits and Capsules Industry
Several factors are accelerating growth within the Sodium Iodide I-131 kits and capsules industry. These include ongoing research and development leading to improved product formulations and delivery methods, increased government funding for cancer research and treatment, rising healthcare expenditure globally, and increased awareness of thyroid disorders and their effective treatment. Furthermore, the development of innovative treatment protocols and improved patient management strategies are contributing to the market's growth trajectory.
Leading Players in the Sodium Iodide I-131 Kits and Capsules Market
Curium Pharma
China Isotope & Radiation Corporation (CIRC)
Jubilant Pharmova
PDRadiopharma Inc.
Yantai Dongcheng Pharmaceutical Group Co
NTP Radioisotopes
International Isotopes Inc
ANSTO
POLATOM（NCBJ）
Isotope JSC (Rosatom)
Significant Developments in Sodium Iodide I-131 Kits and Capsules Sector
2020: Several companies announced new partnerships for expanded distribution of I-131 products.
2021: A major clinical trial demonstrated improved efficacy of a novel I-131 formulation.
2022: New regulatory approvals were granted for several I-131 products in key markets.
2023: Several companies invested in expanding their manufacturing capacity to meet growing demand.
Comprehensive Coverage Sodium Iodide I-131 Kits and Capsules Report
This report provides a comprehensive overview of the Sodium Iodide I-131 kits and capsules market, encompassing market size estimations, growth projections, competitive analysis, and key industry trends. It delves into the driving forces, challenges, and opportunities shaping the market, offering valuable insights for stakeholders seeking to understand and capitalize on the growth potential within this dynamic sector. The report further segments the market by product type, application, and geography, providing detailed market analyses for each segment. This detailed breakdown provides valuable information to companies looking for future market growth and potential investments.
Sodium Iodide I-131 Kits and Capsules Segmentation
1. Type
1.1. /> Capsule
1.2. Solution
2. Application
2.1. /> Hyperthyroidism Treatment
2.2. Thyroid Cancer Treatment
Sodium Iodide I-131 Kits and Capsules Segmentation By Geography
1. North America
1.1. United States
1.2. Canada
1.3. Mexico
2. South America
2.1. Brazil
2.2. Argentina
2.3. Rest of South America
3. Europe
3.1. United Kingdom
3.2. Germany
3.3. France
3.4. Italy
3.5. Spain
3.6. Russia
3.7. Benelux
3.8. Nordics
3.9. Rest of Europe
4. Middle East & Africa
4.1. Turkey
4.2. Israel
4.3. GCC
4.4. North Africa
4.5. South Africa
4.6. Rest of Middle East & Africa
5. Asia Pacific
5.1. China
5.2. India
5.3. Japan
5.4. South Korea
5.5. ASEAN
5.6. Oceania
5.7. Rest of Asia Pacific
Sodium Iodide I-131 Kits and Capsules Regional Market Share
Loading chart...
Geographic Coverage of Sodium Iodide I-131 Kits and Capsules
Higher Coverage
Lower Coverage
No Coverage
Sodium Iodide I-131 Kits and Capsules REPORT HIGHLIGHTS
Aspects
Details
Study Period
2020-2034
Base Year
2025
Estimated Year
2026
Forecast Period
2026-2034
Historical Period
2020-2025
Growth Rate
CAGR of 9.18% from 2020-2034
Segmentation
By Type
/> Capsule
Solution
By Application
/> Hyperthyroidism Treatment
Thyroid Cancer Treatment
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
United Kingdom
Germany
France
Italy
Spain
Russia
Benelux
Nordics
Rest of Europe
Middle East & Africa
Turkey
Israel
GCC
North Africa
South Africa
Rest of Middle East & Africa
Asia Pacific
China
India
Japan
South Korea
ASEAN
Oceania
Rest of Asia Pacific
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
2.1. Introduction
3. Market Dynamics
3.1. Introduction
3.2. Market Drivers
3.3. Market Restrains
3.4. Market Trends
4. Market Factor Analysis
4.1. Porters Five Forces
4.2. Supply/Value Chain
4.3. PESTEL analysis
4.4. Market Entropy
4.5. Patent/Trademark Analysis
5. Global Sodium Iodide I-131 Kits and Capsules Analysis, Insights and Forecast, 2020-2032
5.1. Market Analysis, Insights and Forecast - by Type
5.1.1. /> Capsule
5.1.2. Solution
5.2. Market Analysis, Insights and Forecast - by Application
5.2.1. /> Hyperthyroidism Treatment
5.2.2. Thyroid Cancer Treatment
5.3. Market Analysis, Insights and Forecast - by Region
5.3.1. North America
5.3.2. South America
5.3.3. Europe
5.3.4. Middle East & Africa
5.3.5. Asia Pacific
6. North America Sodium Iodide I-131 Kits and Capsules Analysis, Insights and Forecast, 2020-2032
6.1. Market Analysis, Insights and Forecast - by Type
6.1.1. /> Capsule
6.1.2. Solution
6.2. Market Analysis, Insights and Forecast - by Application
6.2.1. /> Hyperthyroidism Treatment
6.2.2. Thyroid Cancer Treatment
7. South America Sodium Iodide I-131 Kits and Capsules Analysis, Insights and Forecast, 2020-2032
7.1. Market Analysis, Insights and Forecast - by Type
7.1.1. /> Capsule
7.1.2. Solution
7.2. Market Analysis, Insights and Forecast - by Application
7.2.1. /> Hyperthyroidism Treatment
7.2.2. Thyroid Cancer Treatment
8. Europe Sodium Iodide I-131 Kits and Capsules Analysis, Insights and Forecast, 2020-2032
8.1. Market Analysis, Insights and Forecast - by Type
8.1.1. /> Capsule
8.1.2. Solution
8.2. Market Analysis, Insights and Forecast - by Application
8.2.1. /> Hyperthyroidism Treatment
8.2.2. Thyroid Cancer Treatment
9. Middle East & Africa Sodium Iodide I-131 Kits and Capsules Analysis, Insights and Forecast, 2020-2032
9.1. Market Analysis, Insights and Forecast - by Type
9.1.1. /> Capsule
9.1.2. Solution
9.2. Market Analysis, Insights and Forecast - by Application
9.2.1. /> Hyperthyroidism Treatment
9.2.2. Thyroid Cancer Treatment
10. Asia Pacific Sodium Iodide I-131 Kits and Capsules Analysis, Insights and Forecast, 2020-2032
10.1. Market Analysis, Insights and Forecast - by Type
10.1.1. /> Capsule
10.1.2. Solution
10.2. Market Analysis, Insights and Forecast - by Application
10.2.1. /> Hyperthyroidism Treatment
10.2.2. Thyroid Cancer Treatment
11. Competitive Analysis
11.1. Global Market Share Analysis 2025
11.2. Company Profiles
11.2.1 Curium Pharma
11.2.1.1. Overview
11.2.1.2. Products
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Financials (Based on Availability)
11.2.2 China Isotope & Radiation Corporation (CIRC)
11.2.2.1. Overview
11.2.2.2. Products
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Financials (Based on Availability)
11.2.3 Jubilant Pharmova
11.2.3.1. Overview
11.2.3.2. Products
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Financials (Based on Availability)
11.2.4 PDRadiopharma Inc.
11.2.4.1. Overview
11.2.4.2. Products
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Financials (Based on Availability)
11.2.5 Yantai Dongcheng Pharmaceutical Group Co
11.2.5.1. Overview
11.2.5.2. Products
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Financials (Based on Availability)
11.2.6 NTP Radioisotopes
11.2.6.1. Overview
11.2.6.2. Products
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Financials (Based on Availability)
11.2.7 International Isotopes Inc
11.2.7.1. Overview
11.2.7.2. Products
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Financials (Based on Availability)
11.2.8 ANSTO
11.2.8.1. Overview
11.2.8.2. Products
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Financials (Based on Availability)
11.2.9 POLATOM（NCBJ）
11.2.9.1. Overview
11.2.9.2. Products
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Financials (Based on Availability)
11.2.10 Isotope JSC (Rosatom)
11.2.10.1. Overview
11.2.10.2. Products
11.2.10.3. SWOT Analysis
11.2.10.4. Recent Developments
11.2.10.5. Financials (Based on Availability)
List of Figures
Figure 1: Global Sodium Iodide I-131 Kits and Capsules Revenue Breakdown (billion, %) by Region 2025 & 2033
Figure 2: North America Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Type 2025 & 2033
Figure 3: North America Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Type 2025 & 2033
Figure 4: North America Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Application 2025 & 2033
Figure 5: North America Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Application 2025 & 2033
Figure 6: North America Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Country 2025 & 2033
Figure 7: North America Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Country 2025 & 2033
Figure 8: South America Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Type 2025 & 2033
Figure 9: South America Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Type 2025 & 2033
Figure 10: South America Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Application 2025 & 2033
Figure 11: South America Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Application 2025 & 2033
Figure 12: South America Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Country 2025 & 2033
Figure 13: South America Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Country 2025 & 2033
Figure 14: Europe Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Type 2025 & 2033
Figure 15: Europe Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Type 2025 & 2033
Figure 16: Europe Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Application 2025 & 2033
Figure 17: Europe Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Application 2025 & 2033
Figure 18: Europe Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Country 2025 & 2033
Figure 19: Europe Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Country 2025 & 2033
Figure 20: Middle East & Africa Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Type 2025 & 2033
Figure 21: Middle East & Africa Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Type 2025 & 2033
Figure 22: Middle East & Africa Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Application 2025 & 2033
Figure 23: Middle East & Africa Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Application 2025 & 2033
Figure 24: Middle East & Africa Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Country 2025 & 2033
Figure 25: Middle East & Africa Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Country 2025 & 2033
Figure 26: Asia Pacific Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Type 2025 & 2033
Figure 27: Asia Pacific Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Type 2025 & 2033
Figure 28: Asia Pacific Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Application 2025 & 2033
Figure 29: Asia Pacific Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Application 2025 & 2033
Figure 30: Asia Pacific Sodium Iodide I-131 Kits and Capsules Revenue (billion), by Country 2025 & 2033
Figure 31: Asia Pacific Sodium Iodide I-131 Kits and Capsules Revenue Share (%), by Country 2025 & 2033
List of Tables
Table 1: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Type 2020 & 2033
Table 2: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Application 2020 & 2033
Table 3: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Region 2020 & 2033
Table 4: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Type 2020 & 2033
Table 5: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Application 2020 & 2033
Table 6: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Country 2020 & 2033
Table 7: United States Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 8: Canada Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 9: Mexico Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 10: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Type 2020 & 2033
Table 11: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Application 2020 & 2033
Table 12: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Country 2020 & 2033
Table 13: Brazil Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 14: Argentina Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 15: Rest of South America Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 16: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Type 2020 & 2033
Table 17: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Application 2020 & 2033
Table 18: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Country 2020 & 2033
Table 19: United Kingdom Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 20: Germany Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 21: France Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 22: Italy Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 23: Spain Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 24: Russia Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 25: Benelux Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 26: Nordics Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 27: Rest of Europe Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 28: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Type 2020 & 2033
Table 29: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Application 2020 & 2033
Table 30: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Country 2020 & 2033
Table 31: Turkey Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 32: Israel Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 33: GCC Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 34: North Africa Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 35: South Africa Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 36: Rest of Middle East & Africa Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 37: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Type 2020 & 2033
Table 38: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Application 2020 & 2033
Table 39: Global Sodium Iodide I-131 Kits and Capsules Revenue billion Forecast, by Country 2020 & 2033
Table 40: China Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 41: India Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 42: Japan Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 43: South Korea Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 44: ASEAN Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 45: Oceania Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Table 46: Rest of Asia Pacific Sodium Iodide I-131 Kits and Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders
Secondary Research
Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Sodium Iodide I-131 Kits and Capsules?
The projected CAGR is approximately 9.18%.
2. Which companies are prominent players in the Sodium Iodide I-131 Kits and Capsules?
Key companies in the market include Curium Pharma, China Isotope & Radiation Corporation (CIRC), Jubilant Pharmova, PDRadiopharma Inc., Yantai Dongcheng Pharmaceutical Group Co, NTP Radioisotopes, International Isotopes Inc, ANSTO, POLATOM（NCBJ）, Isotope JSC (Rosatom).
3. What are the main segments of the Sodium Iodide I-131 Kits and Capsules?
The market segments include Type, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD 14.31 billion as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4480.00, USD 6720.00, and USD 8960.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Sodium Iodide I-131 Kits and Capsules," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Sodium Iodide I-131 Kits and Capsules report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Sodium Iodide I-131 Kits and Capsules?
To stay informed about further developments, trends, and reports in the Sodium Iodide I-131 Kits and Capsules, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Sodium Iodide I-131 Kits and Capsules